HomeNews

News

To These Dealing with Finish of Life From Most cancers

Mary Sansone is a two-time survivor of acute myeloid leukemia. Compensate for all of Mary's blogs right here!I'm a survivor of acute myeloid...

How 5-Fraction SBRT Compares With Conventional Radiation in Prostate Most cancers

For sufferers with low- to intermediate-risk localized prostate most cancers, five-fraction stereotactic physique radiotherapy (SBRT) may very well be a extra handy radiation...

Subcutaneous Opdivo Receives FDA Approval for Superior, Metastatic Strong Tumors

The FDA authorised a subcutaneous formulation of Opdivo for beforehand authorised strong tumor indications.The Meals and Drug Administration (FDA) authorised Opdivo Qvantig (nivolumab...

FDA Approves Tevimbra Plus Chemo for Gastric, Gastroesophageal Junction Adenocarcinoma

Tevimbra plus chemotherapy has been accredited to deal with unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma (G/GEJ) whose tumors categorical PD-L1.The...

How a Caregiver Grew to become an MPN Advocate

An advocate’s private connection to most cancers has formed his strategy to offering assist to sufferers with myeloproliferative neoplasms (MPNs).Richard Winneker, a affected...

Hot Topics